DCGI grants EUA to Corbevax for those aged 5-12 Covaxin for 6-12 age group
New Delhi Apr 26 PTI Indias drug regulator has granted emergency use authorisation for Biological Es COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotechs Covaxin for children in the age group of six to 12 years official sources said on TuesdayThe approval by the Drugs Controller General of India DCGI comes following recommendations by the Subject Expert Committee SEC on COVID-19 of the Central Drugs Standard Control OrganisationCDSCOThe SEC had last week reviewed the application of both the companies seeking emergency use authorisation for Corbevax and Covaxin for use in children of five to 12 years andsix to 12 years age group respectivelyBiological Es Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years Covaxin has been granted Emergency Use Listing EUL by the DCGI for the age group of 12 to 18 years on December 24 2021India began inoculating children aged 12-14 on March 16 The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers getting inoculated in the first phase Vaccination of frontline workers started from February 2 last yearThe next phase of COVID-19 vaccination commenced on March 1 last year for people over 60 years of age and those aged 45 and above with specified co-morbid conditionsIndia launched vaccination for all people aged more than 45 years from April 1 last year The government then decided to expand its vaccination drive by allowing everyone above 18 years of age to be inoculated against the viral disease from May 1 last yearThe next phase of vaccination commenced on January 3 for adolescents in the age group of 15-18 yearsIndia began administering precaution doses of vaccines to healthcare and frontline workers and those aged 60 and above with comorbidities from January 10 Precaution doses of COVID-19 vaccines to all aged above 18 years were allowed at private vaccination centres from April 10 PTI PLB NSD NSD
New Delhi Apr 26 PTI Indias drug regulator has granted emergency use authorisation for Biological Es COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotechs Covaxin for children in the age group of six to 12 years official sources said on TuesdayThe approval by the Drugs Controller General of India DCGI comes following recommendations by the Subject Expert Committee SEC on COVID-19 of the Central Drugs Standard Control OrganisationCDSCOThe SEC had last week reviewed the application of both the companies seeking emergency use authorisation for Corbevax and Covaxin for use in children of five to 12 years andsix to 12 years age group respectivelyBiological Es Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years Covaxin has been granted Emergency Use Listing EUL by the DCGI for the age group of 12 to 18 years on December 24 2021India began inoculating children aged 12-14 on March 16 The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers getting inoculated in the first phase Vaccination of frontline workers started from February 2 last yearThe next phase of COVID-19 vaccination commenced on March 1 last year for people over 60 years of age and those aged 45 and above with specified co-morbid conditionsIndia launched vaccination for all people aged more than 45 years from April 1 last year The government then decided to expand its vaccination drive by allowing everyone above 18 years of age to be inoculated against the viral disease from May 1 last yearThe next phase of vaccination commenced on January 3 for adolescents in the age group of 15-18 yearsIndia began administering precaution doses of vaccines to healthcare and frontline workers and those aged 60 and above with comorbidities from January 10 Precaution doses of COVID-19 vaccines to all aged above 18 years were allowed at private vaccination centres from April 10 PTI PLB NSD NSD
